Why is Global Longlife falling/rising?

As of 27-Jun, Global Longlife Hospital and Research Ltd is experiencing a decline in its stock price, currently at 24.25, which reflects a decrease of 0.69 or 2.77%. The stock has underperformed significantly, with a 1-week return of -7.27% and a 1-month return of -19.17%. Today's performance indicates that it has underperformed its sector by 5.43%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a persistent downward trend. There has also been a notable decline in investor participation, with delivery volume falling by 31.82% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the stock's performance contrasts sharply with the benchmark, as the Sensex has gained 2.00% over the past week and 3.07% over the past month. This indicates that while the overall market is experiencing positive momentum, Global Longlife is struggling significantly. Year-to-date, the stock has declined by 21.77%, while the Sensex has increased by 7.58%, further highlighting the disparity in performance. The hospital and healthcare services sector has seen a gain of 2.67%, which underscores the challenges faced by Global Longlife in capitalizing on sector growth.